Black seed Nigella sativa L.
Also called: nigella, black cumin, black caraway, kalonji, Nigella cretica Mill. (synonym of N. sativa var. sativa)
Black seed is the small black seed of Nigella sativa, used as a spice and in traditional medicine, and sold as whole or powdered seed, pressed seed oil and capsules. Many small trials exist; an NIH review calls the overall evidence not very convincing.
- Category
- Botanical
- Part used
- Seed; cold-pressed (fixed) seed oil; essential oil
- Strongest evidence
- B Some positive trials
- Native range
- Native from Romania to western and south-western Iran (POWO: "Romania to W. & SW. Iran"); widely introduced and cultivated elsewhere
- Reviewed
- 2026-10-29
Class 1 Well studied in people. A 2022 meta-analysis (Front Nutr) pooled 11 RCTs (666 adults with prediabetes or type 2 diabetes) of Nigella sativa oil, capsules, tablets or powder; trials combining N. sativa with other supplements were excluded. [9]
Fact-checked 2026-10-29 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BHeart and blood vessels2 topics
BBlood sugar and weight1 topic
CSeveral areas, whole body or blood1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Blood pressure in adults | B | A 2023 meta-analysis of randomized trials found systolic pressure 3.06 mmHg and diastolic 2.69 mmHg lower than control, with very high heterogeneity between trials (I² 84.7% and 97.3%). [3] |
| Blood lipids, body weight and other cardiovascular risk factors | B | A 2025 meta-analysis of 82 studies (5,026 participants; 200–4,600 mg/day for 1–48 weeks) reported improvements in lipids, weight measures, blood pressure, glucose and inflammatory markers. [4] |
| Fasting glucose and HbA1c in adults | B | A 2024 meta-analysis of 30 randomized trials found lower fasting glucose and HbA1c but no change in insulin or HOMA-IR; heterogeneity was very high (I² over 90%). [5] |
| Overall clinical benefit | C | NIH LiverTox notes trials of lipid lowering, glucose, HbA1c and blood pressure, and states that the overall evidence for clinical benefit is not very convincing. [1] |
Main constituents: Fatty oils (linoleic, oleic and palmitic acids) and volatile oils including thymoquinone, the suspected major bioactive component [1]; Seed oil also contains phytosterols, thymol and dithymoquinone; seeds contain isoquinoline alkaloids [2]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Trials cited by LiverTox used powdered extract 1 g twice daily (6 weeks) or 2 g daily (12 weeks), oil 450 mg three times daily (3 months), a 200 mg oil product with 5% thymoquinone daily (9 days), and seed oil giving 2.5 mg thymoquinone every 8 hours (30 days). [1]
- Across the 2025 meta-analysis, doses ranged from 200 to 4,600 mg/day for 1 to 48 weeks. [4]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Score EABCDEA: well known causeE: unlikely cause
LiverTox likelihood score E (unlikely cause of clinically apparent liver injury), chapter updated April 27, 2023: no published reports of serum …
Details and sources - Pregnancy and breastfeedingA French order (June 24, 2014) authorizes nigella seed and oil in food supplements but requires a label warning against use in children, adolescents, …
1 statement in the profile.
Details and sources - Interactions with medicines2 listed
Drugs metabolized by CYP2D6 or CYP3A4; Warfarin
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notificationsSee details
FDA does not approve dietary supplements.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- Side effects are usually uncommon, mild and transient: abdominal discomfort, bloating, altered taste, diarrhea and headache. Rare, potentially severe rash and hypersensitivity reactions are reported. [1]
- LiverTox likelihood score E (unlikely cause of clinically apparent liver injury); no published reports of liver injury attributable to black cumin seed products. [1]
- Contact dermatitis, and one case of eosinophilia and systemic symptoms, have been reported after applying the oil to skin. [6]
- France (order of June 24, 2014) authorizes nigella seed and oil in food supplements but requires a label warning against use by children, adolescents, and pregnant or breastfeeding women because of isoquinoline alkaloids. [2]
Interactions
| With | What happens |
|---|---|
| Drugs metabolized by CYP2D6 or CYP3A4 | Nigella sativa inhibits these enzymes in studies; clinical relevance is not known. [6] |
| Warfarin | Thymoquinone was shown to inhibit warfarin activity; clinical significance is not known. [6] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
- The ABC-AHP-NCNPR Botanical Adulterants Prevention Bulletin (2022, updated 2023) reports seed oil diluted with cheaper vegetable oils (e.g. sunflower, soybean, canola) and seed substitution or confusion with other Nigella species and look-alike seeds. [2]
- There is no US or European Pharmacopoeia monograph for nigella seed or seed oil. Thymoquinone content varies significantly: 0.05–0.619% in 10 Turkish cold-pressed oils and 0.348–0.873% in 6 US cold-pressed oils. [2]
Regulatory status
- US: nigella seed and its oil are GRAS for use as a spice, natural seasoning or flavoring and are accepted as a component of dietary supplements. Canada: regulated as medicinal ingredients of licensed natural health products. [2]
- US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; manufacturers and distributors have initial responsibility for their safety. [7]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI list (dated July 9, 2026; checked 2026-10-29) has 2 notifications naming black seed (Nigella sativa): NDI 468 (Rpt/NDI 413), submitted 2007-07-06, FDA response dated 2007-09-18; and NDI 585, submitted 2009-05-07, FDA response dated 2009-06-23. The list gives the date of FDA's response letter but not what it said. [P3]
- Nigella seed and its oil are classified by FDA as Generally Recognized as Safe (GRAS) for use as a spice, natural seasoning or flavoring (as reported by the BAPP bulletin). [P2]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- LiverTox likelihood score E (unlikely cause of clinically apparent liver injury), chapter updated April 27, 2023: no published reports of serum enzyme elevations or clinically apparent liver injury attributable to black cumin seed products. [P1]
Interactions with medicines
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- BAPP bulletin 'Adulteration of nigella (Nigella sativa) seed and seed oil' (2022; v2 2023): seed oil is a target for dilution with cheaper oils such as sunflower, soybean, corn, canola, grape seed or walnut (5 of 40 Turkish products adulterated in a 2022 study); seeds may be mixed with N. damascena or N. arvensis (which lack thymoquinone) or look-alike seeds; two of ten market seed samples were onion (Allium cepa) and Clitoria guianensis by DNA barcoding. [P2]
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination of each dietary-ingredient component (21 CFR 111.75(a)(1)(i)) — Required by the US dietary supplement cGMP rule for any component that is a dietary ingredient, unless FDA grants an exemption petition under 111.75(a)(1)(ii). [P7]
- Seed identity by organoleptic, macroscopic and microscopic examination (DNA where needed) — Substitution with other Nigella species and look-alike seeds, some highly toxic (Agrostemma githago, Argemone mexicana), is documented. [P2]
- Fatty-acid and sterol profile by GC (oil); FTIR/fluorescence screening — GC-FID and/or GC-MS is the preferred method for nigella seed oil analysis and is used to detect adulteration with vegetable oils. [P2]
- Thymoquinone by HPLC — Thymoquinone content of commercial oils varies significantly (e.g. 0.05–0.619% in Turkish and 0.348–0.873% in US cold-pressed oils); care is needed when measuring thymoquinone by GC because of stability issues. [P2]
Supply and conservation
- Extensively cultivated from Morocco to northern India and Bangladesh, China, the Pacific Rim, East Africa and Russia for use as a spice. [P2]
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- A French order (June 24, 2014) authorizes nigella seed and oil in food supplements but requires a label warning against use in children, adolescents, and pregnant or breastfeeding women because of isoquinoline alkaloids. [P2]
Sources for this profile
- NIH LiverTox (NIDDK). Black Cumin Seed (Last Update: April 27, 2023), 2023-04-27. ncbi.nlm.nih.gov
- Orhan N. Adulteration of nigella (Nigella sativa) seed and seed oil. Botanical Adulterants Prevention Bulletin. ABC-AHP-NCNPR Botanical Adulterants Prevention Program; October 2022, Version 2 updated September 2023, 2023-09. umb.herbalgram.org
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications, Agents classified by the IARC Monographs, Volumes 1–142 (checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
- National Toxicology Program (NIEHS). Technical Reports list (checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- Memorial Sloan Kettering Cancer Center. About Herbs: Nigella sativa (last updated August 10, 2023), 2023-08-10. mskcc.org
- eCFR. 21 CFR 111.75 (Title 21 up to date as of 10/27/2026), 2026-10-27. ecfr.gov
Sources
- NIH LiverTox (NIDDK). Black Cumin Seed (Last Update: April 27, 2023), 2023-04-27. ncbi.nlm.nih.gov
- Orhan N. Adulteration of nigella (Nigella sativa) seed and seed oil. Botanical Adulterants Prevention Bulletin. ABC-AHP-NCNPR Botanical Adulterants Prevention Program; October 2022, Version 2 updated September 2023, 2023-09. umb.herbalgram.org
- Kavyani Z, et al. Antihypertensive effects of Nigella sativa supplementation: An updated systematic review and meta-analysis of randomized controlled trials. Phytother Res 2023 (PMID 37341696), 2023-08. pubmed.ncbi.nlm.nih.gov
- Jafari A, et al. Does Nigella sativa supplementation improve cardiovascular disease risk factors? A comprehensive GRADE-assessed systematic review and dose-response meta-analysis of 82 randomized controlled trials. Pharmacol Res 2025 (PMID 40714301), 2025-09. pubmed.ncbi.nlm.nih.gov
- Shirvani S, et al. The effect of Nigella sativa supplementation on glycemic status in adults: An updated systematic review and meta-analysis of randomized controlled trials. Prostaglandins Other Lipid Mediat 2024 (PMID 39181437), 2024-10. pubmed.ncbi.nlm.nih.gov
- Memorial Sloan Kettering Cancer Center. About Herbs: Nigella sativa (last updated August 10, 2023), 2023-08-10. mskcc.org
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
- Plants of the World Online (POWO), Royal Botanic Gardens, Kew; WCVP data (Govaerts et al., Sci Data 2021). Nigella sativa L. (accessed 2026-10-29), 2026-10-29. powo.science.kew.org
- Saadati S, et al. Nigella sativa supplementation improves cardiometabolic indicators in population with prediabetes and type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Front Nutr 2022;9:977756 (PMID 36034891), 2022-08-11. pubmed.ncbi.nlm.nih.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.